Hypertension Treatment in Nigeria: HEARTS-D Integration for Diabetes Care
Official title: Transforming Hypertension Treatment in Nigeria Using a Type II Hybrid, Interrupted Time Series Design - Aim 3
Run by Washington University School of Medicine · NCT07589387 · Data updated 2026-11-12
This program tests a HEARTS-D bundle in 10 primary health centers in Nigeria to help people with diabetes manage blood pressure and glucose using new tools and training.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2800 (estimated) |
| Sponsor | Washington University School of Medicine Academic / other |
| Locations | 10 sites (Abaji and 9 other locations) |
| Status | Recruiting |
| Started | February 14, 2026 |
| Main results expected | April 30, 2029 |
| Study ends | January 31, 2030 |
| Registry record updated | October 16, 2026 |
| Trial ID | NCT07589387 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) with a prior or new diabetes diagnosis and elevated glucose measures who are already on or started on glucose-lowering therapy.
✕Probably not a fit
Patients without access to the full HEARTS-D bundle or who do not meet glucose criteria may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study expands the HEARTS framework to integrate diabetes care at primary health centers in the Federal Capital Territory. It uses the HEARTS-D package, metformin and other diabetes meds, point-of-care glucose testing, and targeted training with quarterly supervision for community health workers. Adults with diabetes or suspected diabetes who meet specific glucose thresholds are enrolled and registered for the program. The focus is on how integrated management affects diabetes control alongside hypertension across previously involved centers. Geographic sites include Abaji and Abuja-area PHCs, under collaboration among Washington University, NHLBI, and local hospitals.
Why it matters
Potential benefit: If successful, patients may experience better diabetes and hypertension control through a streamlined, team-based care approach.
How similar studies have gone: Similar HEARTS-based programs have improved cardiovascular risk factors in primary care settings, though diabetes integration is being tested in this setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aim 3 Inclusion Criteria: Patients will be screened for diabetes with symptoms of hyperglycemia or BMI \>25 kg/m2 and over the age of 18 years old. Upon first or previous diagnosis, diabetes patients will be registered. * Adults (≥18 years), * Patients with previous diabetes diagnosis * Patients with persistently elevated random glucose \>200 mg/dl, fasting glucose \>126 mg/dl, or hemoglobin A1c \>6.5% on two or more occasions (when available) * Patients taking glucose lowering medications * Pregnant women are eligible for this program, or * Cognitively impaired adults are eligible for this program. Exclusion Criteria: * \- This program will not include any of the following special populations: * Individuals who are not yet adults (minors): i.e. infants, children, or teenagers \<18 years old, or * Prisoners or other detained individuals.
Where it's running
-
New Township Abaji
Abaji, Nigeria Recruiting -
Gbagarape PHC
Abuja, Nigeria Recruiting -
Gidan Mangoro
Abuja, Nigeria Recruiting -
Pyakasa PHC
Abuja, Nigeria Recruiting -
Byazhin
Bwari, Nigeria Recruiting -
Gtc Gwagwalada
Gwagwalada, Nigeria Recruiting
Show 4 more locations
-
Old Kutunku
Gwagwalada, Nigeria Recruiting -
Kuje PHC
Kuje, Nigeria Recruiting -
Dabi Bako
Kwali, Nigeria Recruiting -
Kawli
Kwali, Nigeria Recruiting
Study contacts
- Study coordinator: Dike Ojji, MD
- Email: dike.ojji@uniabuja.edu.ng
- Phone: +234-806-009-4456
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Differentiating heart disease in autoimmune vs. type 2 diabetes
This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Reset-INSPIRE: See if CGM can reveal insulin sensitivity in people at risk for MASLD
This study tests whether real-time CGM data can accurately reflect insulin sensitivity in adults without diabetes who are at risk for MASLD.
-
Telemonitoring for Better Glycemic Control in Tunisian Adults with Diabetes
This trial tests whether remote diabetes management through a mobile app and web platform can improve blood sugar control in adults with diabetes in Tunisia compared with standard care.
-
Rapid guideline-based therapy after a heart attack
This project tests whether starting guideline-driven secondary prevention soon after a heart attack helps people who had PCI reach better risk-factor control and fewer heart events.
-
Impact of a Clinical Information System on hospital outcomes for adults with chronic diseases
This study tests whether implementing a Clinical Information System helps reduce readmissions or death within 30 days after hospital discharge for adults with chronic conditions in Alberta.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.